Halasa Natasha B, Barr Frederick E, Johnson Joyce E, Edwards Kathryn M
Division of Pediatric Infectious Disease, Vanderbilt University Medical Center, Nashville, Tennessee 37232-2573, USA.
Pediatrics. 2003 Dec;112(6 Pt 1):1274-8. doi: 10.1542/peds.112.6.1274.
The deaths of 4 infants who had confirmed pertussis infection at our hospital during the past year motivated us to review their cases as well as the use of extracorporeal membrane oxygenation (ECMO) in respiratory failure caused by pertussis.
Retrospective chart reviews of the 4 infants who had pertussis and died at Vanderbilt University Medical Center (VUMC) from May 2001 to May 2002 were conducted. The Extracorporeal Life Support Organization (ELSO) database is an international voluntary registry established in 1986 to compile passive reports of adult and pediatric patients placed on ECMO. We searched this database for pertussis cases and analyzed the clinical outcomes by age, ventilatory management, and measurements of cardiopulmonary status.
All 4 infants who died from pertussis infection at VUMC were younger than 3 months and had severe pulmonary hypertension, and ECMO therapy was considered for respiratory failure. Review of the international ELSO database, focusing only on children from 1986 to July 2002, revealed a total of 23,970 patients placed on ECMO. Since the first pertussis case treated with ECMO in 1990, a total of 61 children with pertussis have been treated with ECMO, representing an increase from 0.09% to 1% of the total cases. Mean age of the pertussis patients placed on ECMO was 88 days (1 day-2.7 years). The overall mortality was 70.5% (43 of 61) but was significantly higher for infants who were younger than 6 weeks (84%) compared with infants who were older than 6 weeks (61%). When evaluating pre-ECMO management, survivors had received significantly higher mean positive end expiratory pressures than nonsurvivors (11.1 +/- 4.5 vs 7.3 +/- 3.1 cmH(2)O) and had significantly higher serum pH than nonsurvivors (7.31 +/- 0.14 vs 7.14 +/- 0.19). There was no effect of duration of ECMO, positive inspiratory pressure, mean arterial pressure, ECMO mode (venoarterial vs venovenous mode), or sex on mortality.
Although the ECMO registry is not an active surveillance system, it suggests that the numbers of children who require ECMO for pertussis have significantly increased. The high fatality rates of pertussis patients who have placed on ECMO are alarming and should stimulate reevaluation of whether this high-risk intervention is beneficial to patients with pertussis. This review, coupled with the 4 infants who died of pertussis at VUMC, suggests that improved measures are needed to prevent pertussis in infants.
过去一年里,我院有4名确诊为百日咳感染的婴儿死亡,这促使我们回顾他们的病例以及体外膜肺氧合(ECMO)在百日咳所致呼吸衰竭中的应用情况。
对2001年5月至2002年5月在范德堡大学医学中心(VUMC)死亡的4例百日咳婴儿进行回顾性病历审查。体外生命支持组织(ELSO)数据库是1986年建立的一个国际自愿登记处,用于汇编接受ECMO治疗的成人和儿科患者的被动报告。我们在该数据库中搜索百日咳病例,并按年龄、通气管理和心肺状态测量结果分析临床结局。
在VUMC死于百日咳感染的所有4例婴儿均小于3个月,且患有严重肺动脉高压,因呼吸衰竭而考虑采用ECMO治疗。对国际ELSO数据库进行回顾,仅关注1986年至2002年7月的儿童病例,结果显示共有23970例患者接受了ECMO治疗。自1990年首例百日咳患者接受ECMO治疗以来,共有61例百日咳儿童接受了ECMO治疗,占总病例数的比例从0.09%增至1%。接受ECMO治疗的百日咳患者的平均年龄为88天(1天至2.7岁)。总体死亡率为70.5%(61例中的43例),但6周龄以下婴儿的死亡率(84%)显著高于6周龄以上婴儿(61%)。在评估ECMO治疗前的管理情况时,存活者接受的平均呼气末正压显著高于非存活者(分别为11.1±4.5与7.3±3.1cmH₂O),且血清pH值显著高于非存活者(分别为7.31±0.14与7.14±0.19)。ECMO治疗持续时间、吸气正压、平均动脉压、ECMO模式(静脉-动脉模式与静脉-静脉模式)或性别对死亡率均无影响。
尽管ECMO登记处并非一个主动监测系统,但它表明因百日咳而需要接受ECMO治疗的儿童数量显著增加。接受ECMO治疗的百日咳患者的高死亡率令人担忧,应促使重新评估这种高风险干预措施对百日咳患者是否有益。这项回顾研究,再加上VUMC的4例死于百日咳的婴儿病例,提示需要采取改进措施来预防婴儿百日咳。